This HTML5 document contains 47 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72092912
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в серпні 1994 scientific article published on 01 August 1994 artículu científicu espublizáu n'agostu de 1994 wetenschappelijk artikel im August 1994 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 1994
p:P577
wds:Q72092912-E45D85BD-CCAE-40B4-875E-3FB235B5741B
wdt:P577
1994-08-01T00:00:00Z
p:P407
wds:Q72092912-BAD10154-1D95-49E8-9E1D-A1928F0E6669
wdt:P407
wd:Q1860
p:P2093
wds:Q72092912-69834B4B-A9CB-4C53-9DDD-994E8055F747 wds:Q72092912-7575F7AC-16FD-4E21-8C19-678D62BDF2DD wds:Q72092912-008C4001-0BDB-404D-A1C9-F4AC935FC3DA wds:Q72092912-8DDD84B6-60DF-471F-97C9-CE22D1A36943
wdt:P2093
Y K Chiang M Ezekowitz U Thadani L Fenney
rdfs:label
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group
skos:prefLabel
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group
schema:name
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group
p:P1476
wds:Q72092912-F62EC850-F1F8-434C-BBB7-6429432B1E67
wdt:P1476
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group
p:P304
wds:Q72092912-B3B6AE9E-0CFF-4E93-BDF2-DE8BEFCC1D11
wdt:P304
726-734
p:P31
wds:Q72092912-39FB9BE2-D662-4D8B-B616-E5C4EA27ED7A
wdt:P31
wd:Q13442814
p:P921
wds:Q72092912-18B53366-1479-4960-B458-E2D0918029D9 wds:Q72092912-8A28A94D-E223-488C-88A8-6D5AF0573E5B
wdt:P921
wd:Q3617336 wd:Q269829
p:P698
wds:Q72092912-CCBC83C3-F091-40A0-88FF-1D44E888E543
wdtn:P698
n10:8044941
wdt:P698
8044941
p:P1433
wds:Q72092912-48B932FE-0DF2-48B1-88B3-28536961B64A
wdt:P1433
wd:Q578091
p:P433
wds:Q72092912-766A7190-A771-4CAE-AE6A-38D3DAB93B72
p:P478
wds:Q72092912-FE9FB48E-4C32-403C-9111-8738B4404F5F
wdt:P433
2
wdt:P478
90
p:P356
wds:Q72092912-0D86F495-65BF-427F-95F1-8054B7A92145
wdtn:P356
n12:01.CIR.90.2.726
wdt:P356
10.1161/01.CIR.90.2.726